CN113493795B - Preparation method of ginsenoside Rh2 - Google Patents
Preparation method of ginsenoside Rh2 Download PDFInfo
- Publication number
- CN113493795B CN113493795B CN202110887422.5A CN202110887422A CN113493795B CN 113493795 B CN113493795 B CN 113493795B CN 202110887422 A CN202110887422 A CN 202110887422A CN 113493795 B CN113493795 B CN 113493795B
- Authority
- CN
- China
- Prior art keywords
- tobacco
- ginsenoside
- pnwrky
- gene
- pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01125—Dammarenediol II synthase (4.2.1.125)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a method for preparing ginsenoside Rh2, which is to use genesDSAnd transcription factor genePnWRKYSimultaneously transferring into tobacco to obtain transgenic tobacco for synthesizing ginsenoside Rh2, wherein the geneDSThe nucleotide sequence of (A) is shown as SEQ ID NO. 1, and the transcription factor genePnWRKYThe nucleotide sequence of (A) is shown as SEQ ID NO. 2; the transgenic plant obtained by the method can synthesize ginsenoside Rh2; the method is simple, easy to operate and suitable for large-scale production and market popularization and application, and provides a new way for obtaining the ginsenoside Rh2.
Description
Technical Field
The invention relates to a method for preparing ginsenoside Rh2, and belongs to the technical field of biological medicine preparation.
Background
Ginsenoside Rh2 is a rare ginsenoside, and ginsenoside Rh2 has effects of regulating immune system, central nervous system, endocrine system, cardiovascular system, etc., and has effects of resisting tumor, anaphylaxis, depression, aging and myocardial ischemia. In the aspect of tumor resistance, rh2 can inhibit the development of various tumors by promoting the apoptosis of tumor cells, retarding the tumor cell cycle and other mechanisms, and can also enhance the anti-tumor immune response of organisms and improve the immunosuppressive effect of chemotherapeutic drugs. Rh2 has significant anti-inflammatory effect, can inhibit inflammatory reaction induced by Lipopolysaccharide (LPS), and has potential therapeutic effect on Alzheimer's disease, allergic asthma, allergic dermatitis, etc.
Rh2 was first discovered in Ginseng radix Rubri, and was later isolated from radix Panacis Quinquefolii, notoginseng radix, etc., and ginsenoside Rh2 content in Ginseng radix extract was minimal. At present, ginsenoside Rh2 is mainly generated by deglycosylation of PPD type ginsenoside; however, the ginseng medicinal material has long cultivation time (3-10 years), the PPD type ginsenoside content in the medicinal material is low, the enzymolysis efficiency of the biotransformation method is not high, and the like, so that the ginsenoside Rh2 has high price, and the application of the ginsenoside Rh2 in the medicine and health care industry is limited to a certain extent.
The transcription factor in the plant can positively or negatively regulate a plurality of key enzyme genes in the synthesis pathway of the secondary metabolite, and the regulation of the transcription factor gene is easier to promote the biosynthesis of the target secondary metabolite compared with the polygene operation. The transcription factor in the plant can simultaneously regulate the expression of a plurality of functional genes, so that the introduction of a key transcription factor can control the simultaneous action of a plurality of functional genes, thereby changing the synthesis of plant secondary metabolites. With the knowledge of plant secondary metabolic pathway and regulation mechanism, based on the function of the transcription factor to coordinately control the transcription of a plurality of function-related genes in the biosynthesis pathway of the secondary metabolite, the transcription factor can be manipulated to realize the 'multi-point regulation' of key enzyme genes, thereby influencing the biosynthesis of the secondary metabolite.
The biosynthetic pathway of ginsenoside Rh2 is basically clear. 2, 3-oxidosqualene generates dammarenediol under the action of Dammarenediol Synthetase (DS), the dammarenediol is hydroxylated to generate protopanoxadiol at C-6 position under the action of CYP450, and then glycosylation is carried out on hydroxyl at C-3 position by glycosyltransferase to generate ginsenoside Rh2. However, glycosylation of PPD-type saponins with a complicated structure by a chemical method is temporarily difficult to achieve.
Tobacco is a commercial crop with mature cultivation technology, has abundant enzyme modification systems in vivo, and has a mature transgenic technology system. Although tobacco may have the potential of synthesizing natural compounds, reports of synthesizing ginsenoside Rh2 in tobacco are not yet seen, and the complete pathway for synthesizing dammarane type tetracyclic triterpene saponins including ginsenoside Rh2 in the tobacco genome is not available, and the tobacco itself does not have the synthetic capacity of the saponins.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a method for preparing ginsenoside Rh2, namely a geneDSAnd transcription factor genePnWRKYSimultaneously transferring into tobacco to obtain transgenic tobacco for synthesizing ginsenoside Rh2, wherein the geneDSThe nucleotide sequence of (A) is shown as SEQ ID NO:1, a transcription factor genePnWRKYThe nucleotide sequence of (A) is shown as SEQ ID NO. 2; the method constructs a way for synthesizing the ginsenoside Rh2 in the tobacco, thereby adopting the tobacco to generate the ginsenoside Rh2.
The purpose of the invention is realized by the following technical scheme:
(1) From notoginseng (Notoginseng)Panax notoginseng) Extracting total RNA from root, reverse transcription synthesizing notoginseng cDNA, PCR amplifying notoginseng gene with the synthesized first strand cDNA as templateDSAnd transcription factor genePnWRKYThe amplification primers were as follows:
DSthe upstream primer of (2) is tacgaattcgagctcggtaccatgtggaagctgaaaggttgctc, and the downstream primer of (3) is gccaagcttgcatgcctgcagtcggatctcggatctctctctctcggcctg;
PnWRKYthe upstream primer is tacgaattcgactcggtacctcagttgaactttgttaggttgtttctga, and the downstream primer is caggttcgacttaggatccttgagtctcatttcaatgaatgaatgacatgacatgtttga;
(2) The target fragments are respectively connected to pCAMBIA2300s plant expression vectors and transformed into agrobacterium. Screening out positive monoclonal by PCR;
(3) Infecting tobacco leaf with positive agrobacterium containing target gene to obtain the geneDSAndPnWRKYa transgenic tobacco plant of two genes;
(4) Extracting total RNA from positive transgenic tobacco, performing reverse transcription to obtain cDNA, and performing RT-PCR to determine whether two genes are expressed;
(5) Drying and grinding the leaves of the transgenic tobacco, soaking the leaves in methanol for 24 hours, then carrying out ultrasonic extraction on saponin, and detecting the types and the content of the ginsenoside in the transgenic tobacco by using HPLC.
The invention is based on the characteristics of easy planting and quick growth of tobacco, and separates the gene from notoginsengDSAnd transcription factor genePnWRKYSimultaneously transferring the gene into tobacco to obtain the expressible geneDSAnd transcription factor genePnWRKYThe experimental result of the transgenic tobacco shows that the obtained transgenic plant can synthesize the ginsenoside Rh2, so that the ginsenoside Rh2 can be more efficiently and conveniently obtained.
Drawings
FIG. 1 shows genes PnWRKYAndDSthe electrophoresis detection result of the PCR product is shown in the figure, wherein M is a DNA Marker;
FIG. 2 isDSA schematic diagram of a PCR detection result of the gene transferred agrobacterium liquid, wherein M is a DNA Marker;1-10 are positive agrobacterium strains; "-" is ddH 2 O is a template; "+" is cDNA as template;
FIG. 3 is a schematic diagram showing the PCR detection result of the PnWRKY transcription factor gene transferred into the Agrobacterium liquid, wherein M is DNA Marker;1-8 are positive agrobacterium strains; "-" is ddH 2 O is a template; "+" is cDNA as template;
FIG. 4 is a schematic diagram showing the results of DNA level detection in transgenic tobacco, in which WT is a wild-type tobacco and T1-T4 are transgenic tobacco lines;
FIG. 5 is a schematic diagram showing the results of detection of RNA level in transgenic tobacco, wherein WT is wild-type tobacco; T1-T4 are transgenic tobacco strains;
FIG. 6 shows the results of the saponin content assay in transgenic tobacco, wherein WT is wild type tobacco; T1-T4 is a transgenic tobacco strain, DD is dammarenediol, and PPD is protopanaxadiol.
Detailed Description
The present invention is further illustrated by the following examples, which are not intended to limit the scope of the present invention, and the methods used in the examples are all conventional methods unless otherwise specified, and reagents used therein are all conventional commercially available reagents or reagents prepared by conventional methods.
Example 1 GeneDSAnd transcription factor genePnWRKYObtaining of
The method comprises the following steps of grinding pseudo-ginseng roots serving as a material by using liquid nitrogen, transferring the powder into a centrifugal tube, extracting total RNA by using a guanidinium isothiocyanate method, and synthesizing a first cDNA chain by using reverse transcriptase M-MLV (promega) and total RNA as a template, wherein a reaction system and an operation process are as follows: mu.g of Total RNA was taken and added with 50 ng oligo (dT), 2. Mu.L dNTP (2.5 mM each) and DEPC water in sequence to a reaction volume of 14.5. Mu.L; after mixing, heating to denature for 5min at 70 ℃, rapidly cooling for 5min on ice, then sequentially adding 4 mu L of 5 XFirst-stand buffer, 0.5 mu L of RNase (200U) and 1 mu L of M-MLV (200U), mixing uniformly, centrifuging for a short time, carrying out warm bath for 1.5 h at 42 ℃, taking out, heating for 10min at 70 ℃, and stopping reaction; the first strand cDNA is synthesized and stored at-20 deg.C for further use.
Using the synthesized first strand cDNA as template, referring to that in the genome of Panax notoginsengDSAndPnWRKYgene sequence, designing positive and negative primers at both ends respectively, cloningDSAndPnWRKYgenes, amplification primers were as follows:
DS FP:ATGTGGAAGCTGAAGGTTGCTC;
DS RP:TCGGATCTCTCTCGGCCTG;
PnWRKY FP: TCAGTTGACCTTGTTAGGTT;
PnWRKY RP: TTAGTCTCAATGAATGAATGACATCTTT;
amplifying a target gene by adopting AdvantageTM 2 PCR Enzyme (Clontech); and (3) PCR reaction conditions: 5min at 94 ℃;30 s at 94 ℃, 30s at 60 ℃, 1min at 72 ℃ and 32 cycles; 7min at 72 ℃; the reaction system (20. Mu.L) was 0.5. Mu.L of cDNA, 2. Mu.L of 10 × Advantage 2 PCR Buffer, 0.4. Mu.L of 50 × dNTP Mix (10 mM each), 0.4. Mu.L of forward primer (10. Mu.M), and 0.4. Mu.L of reverse primer (20. Mu.L)10. μ M), 0.4 μ L of Advantage 2 PCR Polymerase Mix, 15.9 μ L of PCR-Grade water; after the PCR is finished, 10 mu L of the product is taken for agarose gel electrophoresis to detect the specificity and the size of the amplified product; the results are shown in figure 1 of the drawings,PnWRKYthe size of the fragment was 1183bp,DSthe fragment of (3) has a size of 2310bp.
Example 2: geneDSAndPnWRKYconstruction of overexpression vectors
Based on genes in pseudo-ginsengDS、PnWRKYThe nucleotide sequence of (2) is combined with the insertion positions of the two genes in a plant expression vector pCAMBIA2300s at the same time, and a primer with a homology arm is designed by using CE Design software;
DSthe upstream primer is tacgaattcgactcggttacgatgtggaagctgaagggttgctc, and the downstream primer is gccaagcttgcatgcctgcagtcggatctctctctctcggcctg;
PnWRKYthe upstream primer is tacgaattcgactcggtacctcagttgaactttgttaggttgtttctga, and the downstream primer is caggttcgacttaggatccttgagtctcatttcaatgaatgaatgacatgacatgtttga;
by using high fidelity enzymesDS、PnWRKYGene cloning, the PCR reaction is 50 μ L overall, including: prime STAR MAX Premix 25. Mu.L, upstream primer 1. Mu.L, downstream primer 1. Mu.L, cDNA 1. Mu.L, ddH 2 O22 mu L; the PCR reaction conditions were: 3 min at 98 ℃; 10 s at 98 ℃, 15 s at 60 ℃, 15 s at 72 ℃,35 cycles; 5min at 72 ℃. After PCR, running the gel, and recovering the target band after confirming that the amplification is successful, wherein a SanPrep column type DNA gel recovery kit (Shanghai Biotech) is used; taking 1 microliter of the recovered product, detecting the size and concentration of the recovered fragment by agarose gel electrophoresis, and storing at-20 ℃ for later use.
The plant expression vector pCAMBIA2300s is linearized by using restriction endonuclease, and the restriction endonuclease is 15 muL of pCAMBIA2300s plasmid, 5 muL of 10 xM buffer and 2.5 muL of pCAMBIA2300s plasmidKpnI、2.5μL PstI、25μL ddH 2 O, mixing uniformly, centrifuging for a short time, and placing at 37 ℃ for enzyme digestion for 3.5h; dropping the enzyme digestion product in agarose gel for electrophoresis, then carrying out gel recovery on the pCAMBIA2300s carrier large fragment, and using a SanPrep column type DNA gel recovery kit (Shanghai production) in the whole process; collecting 1 μ LThe size and concentration of the recovered fragment were detected by agarose gel electrophoresis of the product, and stored at-20 ℃ for further use. Assembling by using a Clonexpressing Multi One Step Cloning Kit during homologous recombination, and then calculating the using amount of each component according to the operating instructions of a homologous recombinase during homologous recombination and the concentrations of an insert and a vector and the recombination instructions; finally, adding the components into a PCR reaction tube on ice, placing the reaction tube at 37 ℃ for 0.5h, and transforming the recombinant expression plasmid into host strain DH5 alpha competent cells after assembly; coating a plate, wherein the plate is an LB solid culture medium added with kanamycin, culturing for 12-15h in a dark condition in an incubator at 37 ℃, then selecting a single colony on the plate, carrying out PCR amplification on a bacterial liquid, detecting positive clones, and detecting by a sequencing company for further final confirmation; after the assembly is successful, the seed is preserved to obtain the product containingDSAndPnWRKYescherichia coli which is a gene.
Example 3 transformation of Agrobacterium cells
Extracting and purifying pCAMBIA2300S-PnWRKYAnd pCAMBIA2300S-PnDSA plasmid; competent cells of the Agrobacterium LBA4404 strain were prepared and distributed into 1.5mL centrifuge tubes, 150. Mu.L per tube, frozen with liquid nitrogen and stored at-80 ℃ for further use. The plant expression vector pCAMBIA2300S-PnWRKYAnd pCAMBIA2300S-PnDSThe plasmid is transferred into the prepared agrobacterium LBA4404 competent cell; the operation steps are as follows: respectively taking 3 mu g of pCAMBIA2300S-PnWRKYAnd pCAMBIA2300S-PnDSAdding the plasmid into a centrifuge tube containing 150 μ L of competent cells, gently mixing, performing ice bath for 30min, transferring into liquid nitrogen, rapidly freezing for 5min, rapidly placing in 37 deg.C water bath for 5min, and immediately performing ice bath for 2min; the transformed Agrobacterium-infected competent cells were transferred to LB liquid medium (without any antibiotic), cultured with shaking at 200rpm at 28 ℃ for 4 hours to resuscitate the cells, plated on LB solid medium containing 50mg/L kanamycin and 25mg/L rifampicin, and cultured in an inverted state in a 28 ℃ incubator for about 48 hours. Selecting single clone, shaking bacteria, detecting the PCR of bacteria liquid, screening the recombinant vector pCAMBIA2300S-PnWRKYAnd pCAMBIA2300S-PnDSAgrobacterium LBA4404 invasion of plasmidThe PCR results of the tobacco leaf staining are shown in FIG. 2 and FIG. 3, and 10 transgenic pCAMBIA2300S-PnDSPositive Agrobacterium strain of plasmid and 8-strain pCAMBIA2300S-PnWRKYPositive agrobacterium strain of plasmid, and the sequence is identical to the original sequence through sequencing verification, and the strain glycerol is preserved at-80 ℃ for standby.
Example 4: agrobacterium-mediated genetic transformation of tobacco
The transgenic recipient in this experiment was tobacco, tobacco seeds were soaked in 75% alcohol for 30s, washed with sterile water and then washed with 0.1% HgCl 2 Soaking for 8min, washing with sterile water for several times, sowing on 1/2MS culture medium, dark culturing at 28 deg.C for 6d, transferring to light incubator (25 deg.C, 16 h/d light), and subculturing with 1/2MS culture medium once per month.
Taking out the preserved material containing pCAMBIA2300S from a-80 ℃ refrigeratorPnWRKYAnd pCAMBIA2300S-PnDSAgrobacterium LBA4404 strain of plasmid, inoculating Agrobacterium containing target gene in 5mL LB liquid medium containing 50mg/L kanamycin and 20mg/L rifampicin, culturing at 28 deg.C until the medium is turbid; sucking 1mL of turbid bacterial liquid to an LB solid culture medium containing 50mg/L of kanamycin, and culturing for 48h at 28 ℃; then, the agrobacterium on the LB solid medium is scraped to be inoculated into MGL liquid medium added with 20mg/L acetosyringone in a proper amount, and the agrobacterium is activated by shaking culture at 28 ℃ for 2-3 h.
Cutting sterile tobacco seedling leaf into 1cm 2 And completely soaking the left and right leaf discs in the MGL liquid culture medium containing the activated agrobacterium, wherein the dip dyeing time is 15min, sucking bacterial liquid on the surfaces of the leaves by using sterile filter paper, placing the leaf discs on a co-culture medium for room temperature culture, wherein the co-culture medium for tobacco transformation is MS +0.02 mg/L6-BA +2.1mg/L NAA +30g/L sucrose +6g/L agar, co-culturing for 2 days at 22 ℃ in the absence of light, and simultaneously infecting the tobacco leaves by using agrobacterium transformed pCAMBIA2300S empty vector as a blank control.
Transferring the co-cultured leaf disc to an MS screening culture medium added with antibiotics to be divided into seedlings, and screening transgenic plants; the tobacco screening culture medium is MS +0.5 mg/L6-BA +0.1mg/L NAA +30g/L sucrose +6g/L agar +50mg/L kanamycin +200mg/L cephamycin (cefixime sodium salt, cef); during screening culture, transferring the culture bottle to a light incubator for culture (25 ℃,16 h/d light and 8 h/d dark), subculturing by using an MS culture medium containing 50mg/L kanamycin and 200mg/L Cef after the tobacco grows out of buds, wherein the regeneration plant needs to be further screened because the callus differentiation rate of the tobacco is higher, transferring the tobacco regeneration seedling to the MS culture medium containing 50mg/L kanamycin to root the tobacco regeneration seedling, and finally selecting the regeneration seedling with better rooting for further detection;
detecting DNA level, extracting DNA of transgenic tobacco leaf by CTAB method, taking genome DNA of transgenic plant as template, and amplifying geneDS、PnWRKYCarrying out PCR by using the specific primer; the PCR reaction system was 2. Mu.L DNA, 0.4. Mu.L forward primer (10. Mu.M), 0.4. Mu.L reverse primer (10. Mu.M), 10. Mu.L PCR Mix, 7.2. Mu.L ddH 2 O; and (3) PCR reaction conditions: 5min at 94 ℃; 30s at 94 ℃, 90s at 60 ℃, 1min at 72 ℃ and 32 cycles; 7min at 72 ℃; after the PCR is finished, 10 μ L of the product is used for agarose gel electrophoresis to detect positive transgenic plants, the amplification result of part of tobacco transgenic plants is shown in FIG. 4, and 4 positive plants are obtained by detection on the DNA level.
Detecting RNA level, taking positive transgenic single plant on DNA level and tender leaf of non-transgenic tobacco (wild type) to extract total RNA, reverse transcribing to generate cDNA first chain, and using the cDNA first chain as template to amplifyDS、PnWRKYCarrying out PCR on specific primers of the two genes; the PCR reaction system was 1.5. Mu.L of cDNA, 0.4. Mu.L of forward primer (10. Mu.M), 0.4. Mu.L of reverse primer (10. Mu.M), 10. Mu.L of PCR Mix, 7.7. Mu.L of ddH 2 O; and (3) PCR reaction conditions: 5min at 94 ℃; 30s at 94 ℃, 30s at 60 ℃, 90s at 72 ℃ and 32 cycles; 7min at 72 ℃; after the PCR was completed, 10. Mu.L of the resulting mixture was subjected to agarose gel electrophoresis, and each transgenic individual was analyzed based on the PCR resultsDS、PnWRKYExpression of two Gene transcript levels, total RNA extraction method was the same as in example 1, after PCR was completed, 10. Mu.L of the DNA was subjected to agarose gel electrophoresis, and the results of detection of a part of individuals were shown in FIG. 5, and were detected in 4 transgenic individualsDS、PnWRKYBoth genes are expressed in large amounts at the transcriptional level.
Example 5:DS、PnWRKYinfluence of gene expression on synthesis of ginsenoside Rh2 from tobacco
Drying and grinding the leaves of the transgenic tobacco, weighing 1.0g of tobacco powder, soaking the tobacco powder in 50mL of methanol for 24 hours, carrying out ultrasonic extraction for 60min, extracting saponin in the transgenic tobacco, and detecting the types and the content of the ginsenoside in the transgenic tobacco by using HPLC (high performance liquid chromatography); the HPLC detection conditions were as follows: the chromatographic column is Waters-XTerra-MS-C18 (5 μm,250 mm. Times.4.6 mm, USA), and the mobile phase is water and acetonitrile; gradient elution: 0-20min,20% acetonitrile; 20-30min, 20-35% acetonitrile; 30-40min,35% acetonitrile; 40-50min,35-40% acetonitrile; 50-60min,40-100% acetonitrile. The flow rate is 1.0mL/min, the column temperature is 30 ℃, and the detection wavelength is set to be 203nm; ginsenoside Rh2, protopanaxadiol and dammarenediol were detected in 4 transgenic tobacco plants, wherein the content of ginsenoside Rh2 in T4 plants was the highest and reached 11.60. Mu.g/gDW (dry tobacco weight).
Sequence listing
<110> university of Kunming science
<120> preparation method of ginsenoside Rh2
<160> 10
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2310
<212> DNA
<213> pseudo-ginseng (Panax notogeng)
<400> 1
atgtggaagc tgaaggttgc tcaaggaaat gatccatatt tgtatagcac taacaacttt 60
gttggcagac aatattggga gtttcagccc gatgctggta ctccagaaga gagggaagag 120
gttgaaaatg cacgcaagga ttatgtaaac aataaaaagc tacatggagt tcatccatgc 180
agtgatatgc tgatgcgcag gcagcttatt aaagaaagtg gaatcgatct cctaagcata 240
ccgccggtga gattagatga aaacgaacaa gtgaactacg atgcagttac aaccgctgtg 300
aagaaagctc ttcgattgaa ccgggcaatt caagcacacg atggtcactg gccagctgaa 360
aatgcaggct ctttacttta tacacctccc cttatcattg ccctatatat cagcggaacg 420
attgacacta ttctgacaaa acaacacaag aaggaactga ttcgcttcgt ttacaaccat 480
caaaatgagg atggtggatg gggatcctat attgaggggc acagcacgat gattgggtca 540
gtacttagct tcgtgatgtt acgtttgcta ggagaaggat tagctgaatc tgatgatgga 600
aatggtgcag ttgagagagg ccggaagtgg atacttgatc atggaggtgc agccagcata 660
ccctcttggg gaaagactta tctagcggtg cttggagtat atgagtggga agggtgcaac 720
ccgctgcccc cagaattctg gcttttccct tcaagttttc cttttcatcc agcaaaaatg 780
tggatctact gccggtgtac ctacatgcca atgtcgtatt tgtatgggaa gagatatcat 840
ggaccaataa ccgatcttgt tttatctttg agacaagaaa tttacaacat tccttatgag 900
cagataaagt ggaatcaaca gcgccataac tgttgcaagg aggatctcta ctaccctcat 960
tcccttgtac aagacctggt ttgggatggt cttcactact ttagtgaacc attcctcaaa 1020
cgttggccct tcaacaaact gcgaaaaaga ggtctaaaaa gagtggttga actaatgcgc 1080
tatggtgcca ccgagaccag attcataacc acaggaaatg gggaaaaagc tttacaaata 1140
atgagttggt gggcagaaga tcccaatggt gatgagttta aacatcacct tgctagaatt 1200
cctgatttct tatggattgc tgaggatgga atgacagtac agagttttgg tagtcaacta 1260
tgggactgta ttcttgctac tcaagcaatt atcgccacca atatggttga agaatacgga 1320
gattctctta agaaggcgca tttcttcatc aaagaatcgc agataaaaga aaatccaaga 1380
ggagacttct taaaaatgtg tcgacagttt actaaaggtg cgtggacttt ctctgatcaa 1440
gatcatggtt gcgttgtctc ggactgcaca gctgaagcac taaagtgcct tctgttactt 1500
tcacaaatgc cacaggacat tgtcggagaa aaacctaagg ttgagcgatt atatgaggct 1560
gtgaatgttc ttctctattt gcagagtcgt gtaagtggtg gcttcgcagt ttgggagcct 1620
ccagttccaa aaccatattt ggagatgttg aatccttcag aaatttttgc agacattgtt 1680
gttgagagag agcacattga atgcactgca tctgtaatca aaggtctgat ggcatttaaa 1740
tgcttgcatc ctgggcatcg tcagaaagag atagaggatt ctgtggcgaa agccatccgt 1800
tatcttgaaa gaaaccaaat gcctgatggt tcatggtatg gcttttgggg aatttgtttc 1860
ctctatggga cattttttac cctatcaggg tttgcttctg ctgggaggac ttatgacaac 1920
agtgaagcag ttcgtaaggg tgttaaattt ttcctttcaa cacaaaatga agaaggtggt 1980
tggggggaga gtcttgaatc atgcccaagc gagaaattta caccactcaa gggaaacagg 2040
acaaatctag tacaaacatc atgggctatg ctaggtctta tgtttggtgg acaggccgag 2100
agagatccga cacctctgca tagagcagcg aagttgttga tcaatgcgca aatggataat 2160
ggagatttcc ctcaacagga aattactgga gtatactgta aaaatagtat gttacattat 2220
gcggagtaca gaaatatatt tcctctttgg gcactcggag aatatcggaa acgtgtttgg 2280
ttgccaaagc accagcagct caaaatttaa 2310
<210> 2
<211> 1183
<212> DNA
<213> Panax notoginseng (Panax notogeng)
<400> 2
tcagttgacc ttgttaggtt tctgaagatg gaaaatcatg ttgggattca tgaatctgca 60
gcagcagctg agatgaagac tattgaacaa cagctttttc gcatattaca atctcaccat 120
caacaaattc aacttgattt ctccaaaaaa gccgtgaatc gaaccggcca cgcccggttc 180
cgccgtcgac catcagatcc gtctacttct tctcagtctg aaccatttac accgattcag 240
ctcaaaccaa tccctaaacc gtgcgactca aaaatatctg aagaatgtaa aaccaaaaat 300
actccgatat cgtccgggag ctcgtcgatc accggagagg aagggaccgt ttccaatggt 360
aagcgaggat tattaaacac cgcagcagca ccggcaccgc gggtttattc gtccagaaag 420
ccccctcttc cgtcatctca caggaaaaga tgccgtgacc ttgagcccac cgacggaatt 480
tctggcaaac gttcaatttc acgcggctgc cactgttgca agagaaggaa aacagtggag 540
attagaagag taacaacaac aaaaggaggt tcgtcatcca ttcctgcgga tgagtattca 600
tggaggaagt actatcaaaa gttaatcccg ggcactctct tcccaagagg atattacaaa 660
tgcagtagcg taaagggatg cccggcgagg aagcacgcgg tgagatccca agatgatcca 720
acggtgctag tcgtgacata cgaaggagag caccgtcata accgttggat tctaccggga 780
aggctaaata ggagtggtag tgttgttggt atactagtag agtcgaaatg atgaaatcat 840
ttttgtattt atgttttgtg agagaaggat cagatggatg acaggagcag aacatcatct 900
tgcgacttga aagggagcca aggggagctg gtctggtcga gctaaatctc acgactttgc 960
ttgattaatg caaagggagg gctccaggag aataaatgaa tacattcatc catccatcat 1020
atgcatcctt cttgagcaca tacatgaaag gatgtaatta attttatgat gtagtagtaa 1080
ttttctttaa ttagtggatt acaaaagcaa gtgcaagcaa ttcactttta ttacacttca 1140
tctgctggtt gaatcaaaga tgtcattcat tcattgagac taa 1183
<210> 3
<211> 22
<212> DNA
<213> Artificial sequence (Artificial)
<400> 3
atgtggaagc tgaaggttgc tc 22
<210> 4
<211> 19
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
tcggatctct ctcggcctg 19
<210> 5
<211> 20
<212> DNA
<213> Artificial sequence (Artificial)
<400> 5
tcagttgacc ttgttaggtt 20
<210> 6
<211> 28
<212> DNA
<213> Artificial sequence (Artificial)
<400> 6
ttagtctcaa tgaatgaatg acatcttt 28
<210> 7
<211> 43
<212> DNA
<213> Artificial sequence (Artificial)
<400> 7
tacgaattcg agctcggtac catgtggaag ctgaaggttg ctc 43
<210> 8
<211> 40
<212> DNA
<213> Artificial sequence (Artificial)
<400> 8
gccaagcttg catgcctgca gtcggatctc tctcggcctg 40
<210> 9
<211> 46
<212> DNA
<213> Artificial sequence (Artificial)
<400> 9
tacgaattcg agctcggtac ctcagttgac cttgttaggt ttctga 46
<210> 10
<211> 49
<212> DNA
<213> Artificial sequence (Artificial)
<400> 10
caggtcgact ctagaggatc cttagtctca atgaatgaat gacatcttt 49
Claims (1)
1. A method for preparing ginsenoside Rh2 is characterized by comprising the following steps: radix Notoginseng geneDSAnd transcription factor genePnWRKYSimultaneously transferring into tobacco to obtain transgenic tobacco for synthesizing ginsenoside Rh2, wherein the geneDSThe nucleotide sequence of (A) is shown as SEQ ID NO. 1, and the transcription factor genePnWRKYThe nucleotide sequence of (A) is shown as SEQ ID NO. 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110887422.5A CN113493795B (en) | 2021-08-03 | 2021-08-03 | Preparation method of ginsenoside Rh2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110887422.5A CN113493795B (en) | 2021-08-03 | 2021-08-03 | Preparation method of ginsenoside Rh2 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113493795A CN113493795A (en) | 2021-10-12 |
CN113493795B true CN113493795B (en) | 2022-10-28 |
Family
ID=77996753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110887422.5A Active CN113493795B (en) | 2021-08-03 | 2021-08-03 | Preparation method of ginsenoside Rh2 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113493795B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113549649B (en) * | 2021-08-05 | 2022-07-01 | 昆明理工大学 | Preparation method of ginsenoside F1 |
CN116656727B (en) * | 2023-06-12 | 2024-04-16 | 昆明理工大学 | Preparation method of panax japonicus saponin IVa |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014051215A1 (en) * | 2012-09-27 | 2014-04-03 | Korea Advanced Institute Of Science And Technology | Novel udp-glycosyltransferase derived from ginseng and use thereof |
CN105441461A (en) * | 2016-01-06 | 2016-03-30 | 昆明理工大学 | Application of panaxnotoginseng transcription factor gene PnWRKY1 |
CN106350565A (en) * | 2016-09-12 | 2017-01-25 | 中国科学院天津工业生物技术研究所 | Production method of rare ginsenoside Rh2 |
CN111217896A (en) * | 2020-02-28 | 2020-06-02 | 天津大学 | Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng |
CN113549649A (en) * | 2021-08-05 | 2021-10-26 | 昆明理工大学 | Preparation method of ginsenoside F1 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101479608B1 (en) * | 2012-09-27 | 2015-01-06 | 한국과학기술원 | Novel UDP-glycosyltransferase derived from ginseng and use thereof |
US10806119B2 (en) * | 2013-06-05 | 2020-10-20 | Yeda Research And Development Co. Ltd. | Plant with altered content of steroidal alkaloids |
EP3137612A4 (en) * | 2014-04-30 | 2018-01-24 | Korea Advanced Institute Of Science And Technology | A novel method for glycosylation of ginsenoside using a glycosyltransferase derived from panax ginseng |
CN110066328B (en) * | 2019-05-06 | 2022-05-13 | 中南大学 | Ginseng PgMYB2 transcription factor and application thereof in regulating and controlling synthesis of ginsenoside |
-
2021
- 2021-08-03 CN CN202110887422.5A patent/CN113493795B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014051215A1 (en) * | 2012-09-27 | 2014-04-03 | Korea Advanced Institute Of Science And Technology | Novel udp-glycosyltransferase derived from ginseng and use thereof |
CN105441461A (en) * | 2016-01-06 | 2016-03-30 | 昆明理工大学 | Application of panaxnotoginseng transcription factor gene PnWRKY1 |
CN106350565A (en) * | 2016-09-12 | 2017-01-25 | 中国科学院天津工业生物技术研究所 | Production method of rare ginsenoside Rh2 |
CN111217896A (en) * | 2020-02-28 | 2020-06-02 | 天津大学 | Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng |
CN113549649A (en) * | 2021-08-05 | 2021-10-26 | 昆明理工大学 | Preparation method of ginsenoside F1 |
Non-Patent Citations (15)
Title |
---|
Advances in biosynthesis of triterpenoid saponins in medicinal plants;YAO Lu等;《Chinese Journal of Natural Medicines》;20200620(第06期);25-32 * |
Analysis of the transcriptome of Panax notoginseng root uncovers putative triterpene saponin-biosynthetic genes and genetic markers;Luo H等;《BMC Genomics》;20111223;第12卷;doi: 10.1186/1471-2164-12-S5-S5 * |
Dammarenediol-II production confers TMV tolerance in transgenic tobacco expressing Panax ginseng dammarenediol-II synthase;LEE MIHYUN等;《Plant and cell physiology》;20121231;第53卷(第1期);173-182 * |
Panax notoginseng isolate CL13820Contig1_DS dammarenediol-II synthase mRNA, complete cds;Liu,M.H.等;《GenBank Database》;20150428;Accession No. KJ804174.1 * |
Panax notoginseng WRKY1 domain protein mRNA, complete cds;Lu,R.等;《GenBank Database》;20160205;Accession No.KM925138.1 * |
Penicillium sp. YJM-2013 induces ginsenosides biosynthesis in Panax ginseng adventitious roots by inducing plant resistance responses;Shi-hui Wang等;《Chinese Herbal Medicines》;20200718(第03期);58-65 * |
Production of dammarenediol-II triterpene in a cell suspension culture of transgenic tobacco;HAN等;《Plant Cell Reports》;20140228;第33卷(第2期);225-233 * |
The jasmonate-responsive transcription factor CbWRKY24 regulates terpenoid biosynthetic genes to promote saponin biosynthesis in Conyza blinii H. Lév.;Sun WJ等;《J Genet》;20181231;第97卷(第5期);摘要 * |
unctional regulation of a UDP-glucosyltransferase gene (Pq3-O-UGT1) by RNA interference and overexpression in Panax quinquefolius;Lu, C 等;《PLANT CELL TISSUE AND ORGAN CULTURE》;20170601;第129卷(第3期);445-456 * |
三七bHLH转录因子与CAS RNAi协同作用对皂苷合成的影响;于怡琳;《中国优秀博硕士学位论文全文数据库(硕士)农业科技辑》;20200415(第04期);摘要第2、4、5段 * |
三七总皂苷生物合成的关键酶及其调控研究进展;赵灿等;《中草药》;20151012(第19期);第2955页左栏第2段、右栏第1段,第2958页右栏第2-3段,第2962页左栏第3段,图1 * |
三七皂苷前体化合物在烟草中的生物工程合成;李建;《中国学位论文全文数据库》;20171231;全文 * |
人参皂苷生物合成研究进展;林彦萍等;《中国中药杂志》;20161231(第23期);16-26 * |
盾叶薯蓣转录组分析及其皂苷元生物合成关键酶基因的挖掘;李雅静等;《中草药》;20180828(第16期);163-172 * |
调控三七皂苷生物合成PnERF转录因子的克隆与功能研究;卢荣江;《国优秀博硕士学位论文全文数据库(硕士)基础科学辑》;20190315(第03期);A006-48 * |
Also Published As
Publication number | Publication date |
---|---|
CN113493795A (en) | 2021-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Improvement of Tropane alkaloids production in hairy root cultures of'Atropa belladonna'by overexpressing pmt and h6h genes | |
CN113493795B (en) | Preparation method of ginsenoside Rh2 | |
CN113549649B (en) | Preparation method of ginsenoside F1 | |
CN111548399B (en) | MYB transcription factor for regulating and controlling accumulation of tobacco cembratriene diol, coding gene and application | |
CN114736910A (en) | Ginseng PgRb 1-057-containing 001 gene and application thereof | |
Kim et al. | Production of triterpenoid sapogenins in hairy root cultures of Silene vulgaris | |
CN115109787B (en) | Glycosyltransferase gene and application thereof in preparation of pseudo-ginseng/ginsenoside | |
CN115725620B (en) | Method for synthesizing panax japonicus saponins in pseudo-ginseng cells | |
CN116640195B (en) | Citrus CsPIF4 gene, protein coded by same and application thereof | |
CN110079549B (en) | Method for inducing potatoes to rapidly bear potatoes through overexpression of potato StSN2 gene | |
CN114717241B (en) | Rice salt tolerance related gene OsMSRFP, encoding protein and application thereof | |
Guo et al. | High-efficiency Agrobacterium-mediated transformation of Lotus corniculatus L. using phosphomannose isomerase positive selection | |
CN116656727B (en) | Preparation method of panax japonicus saponin IVa | |
CN113186205B (en) | Gene cloning primer, expression vector, catalytic function and application of radix salviae miltiorrhizae CYP76AK5v2 | |
CN114107371B (en) | Cucumber green mottle mosaic virus gene mediated transgenic tobacco method | |
CN115927280B (en) | Horse chestnut 2, 3-oxidation squalene cyclase and encoding gene and application thereof | |
CN117165597B (en) | Application of larch TdERF gene in improving capacity of mountain new Yang Kanglao | |
CN117511970B (en) | Coronatine-induced ginseng PgJOX2 gene and application thereof | |
Seki et al. | The “all-in-one” rol-type binary vectors as a tool for functional genomic studies using hairy roots | |
CN116694672A (en) | Method for heterologously synthesizing ginsenoside Rg3 in plant by utilizing polygene coexpression | |
CN116676329A (en) | Cloning and expression vector construction method of oil tea SQS gene | |
CN117187297A (en) | Method for synthesizing ginsenoside CK in ginseng cells | |
CN117165597A (en) | Application of TdERF11 gene of larch in improving capacity of mountain novel Yang Kanglao | |
CN118147263A (en) | Yeast engineering bacteria of mogrol, siamenoside I and/or mogroside V and application thereof | |
CN117660485A (en) | Application of Arabidopsis ERF012 gene in regulation of seed germination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |